• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Asia-Pacific In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture - Product Image

Asia-Pacific In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

  • Published: January 2013
  • 311 pages
  • GlobalData

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Diagnostica Stago, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Horiba, Ltd.
  • Qiagen N.V.
  • MORE

Asia-Pacific In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Summary

Our new report, “Asia-Pacific In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the Asia-Pacific In Vitro Diagnostics market – Australia, China, India and Japan. The report provides value (USD million) data for all the market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Countries READ MORE >

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 In Vitro Diagnostics in Asia-Pacific
3.1 In Vitro Diagnostics Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018
3.2 In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018
3.3 In Vitro Diagnostics, Asia-Pacific, Company share (2010-2011)
4 In Vitro Diagnostics In Japan
4.1 In Vitro Diagnostics, Japan, Overall Revenue ($m), USD Constant, 2004-2018
4.2 In Vitro Diagnostics, Japan, Distribution Share (2010-2011)
4.3 In Vitro Diagnostics, Japan, Company Share (2010-2011)
5 In Vitro Diagnostics In Australia
5.1 In Vitro Diagnostics, Australia, Overall Revenue ($m), USD Constant, 2004-2018
5.2 In Vitro Diagnostics, Australia, Distribution Share (2010-2011)
5.3 In Vitro Diagnostics, Australia, Company Share (2010-2011)
6 In Vitro Diagnostics In India
6.1 In Vitro Diagnostics, India, Overall Revenue ($m), USD Constant, 2004-2018
6.2 In Vitro Diagnostics, India, Distribution Share (2010-2011)
6.3 In Vitro Diagnostics, India, Company Share (2010-2011)
7 In Vitro Diagnostics In China
7.1 In Vitro Diagnostics, China, Overall Revenue ($m), USD Constant, 2004-2018
7.2 In Vitro Diagnostics, China, Distribution Share (2010-2011)
7.3 In Vitro Diagnostics, China, Company Share (2010-2011)
8 Overview of Key Companies in Asia-Pacific In Vitro Diagnostics
8.1 F. Hoffmann-La Roche Ltd.
8.2 Siemens Healthcare
8.3 Abbott Laboratories
8.4 Sysmex Corporation
8.5 Beckman Coulter, Inc.
8.6 Ortho-Clinical Diagnostics Inc.
8.7 Becton, Dickinson and Company
8.8 Bio-Rad Laboratories, Inc.
8.9 bioMerieux S.A.
8.10 Eiken Chemical Co.,Ltd.
8.11 Shanghai Kehua Bio-engineering Co., Ltd.
8.12 Mindray Medical International Limited
8.13 Alere Inc.
8.14 Transasia Bio-Medicals Ltd.
8.15 Nihon Kohden Corporation
8.16 Horiba, Ltd.
8.17 Qiagen N.V.
8.18 DiaSorin S.p.A
8.19 PerkinElmer, Inc.
8.20 Tosoh Corporation
8.21 Danaher Corporation
8.22 Thermo Fisher Scientific Inc.
8.23 Gen-Probe Incorporated
8.24 Span Diagnostics Ltd.
8.25 Diagnostica Stago, Inc.
8.26 Agappe Diagnostics Ltd.
8.27 Life Technologies Corporation
8.28 Grifols, S.A.
8.29 Trivitron Healthcare Pvt Ltd.
8.30 Himedia Laboratories Pvt. Ltd.
8.31 Tulip Diagnostics (P) Ltd
9 In Vitro Diagnostics Market Pipeline Products
9.1 Clinical Chemisty Market Pipeline Products
9.2 Immuno Chemistry Market Pipeline Products
9.3 Haematology Market Pipeline Products
9.4 Infectious Immunology Market Pipeline Products
9.5 Microbiology Culture Market Pipeline Products
9.6 Histology And Cytology Market Pipeline Products
9.7 Genetic Testing Market Pipeline Products
10 Financial Deals Landscape
10.1 Merger
10.2 Acquisition
10.3 Partnerships
11 Recent Developments
11.1 Strategy And Business Planning
11.2 Research And Development
11.3 Government and Public Interest
11.4 Product News
12 Appendix
12.1 Definitions of Markets Covered in the Report
12.2 Research Methodology
12.3 Secondary Research
12.4 Primary Research
12.5 Models
12.6 Forecasts
12.7 Expert Panels
12.8 Consulting
12.9 Currency Conversion
12.10 Contact Us
12.11 Disclaimer

1.1 List of Tables
Table 1: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018
Table 2: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018
Table 3: In vitro diagnostics, Asia-Pacific, Cross-Category Analysis, 2004-2018
Table 4: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 5: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 6: In Vitro Diagnostics, Asia-Pacific, Company share by Revenue ($m), USD Constant, 2010-2011
Table 7: In Vitro Diagnostics, Japan, Overall Revenue ($m), USD Constant, 2004-2018
Table 8: In Vitro Diagnostics, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 9: In Vitro Diagnostics, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 10: Clinical Chemistry, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 11: Genetic Testing, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 12: Haematology, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 13: Histology And Cytology, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 14: Immuno Chemistry, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 15: Infectious Immunology, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Microbiology Culture, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 17: In Vitro Diagnostics, Japan, Company Share, USD Constant, (2010-2011)
Table 18: Clinical Chemistry, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 19: Genetic Testing, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 20: Haematology, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 21: Histology And Cytology, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 22: Immuno Chemistry, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 23: Infectious Immunology, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 24: Microbiology Culture, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 25: In Vitro Diagnostics, Australia, Overall Revenue ($m), USD Constant, 2004-2018
Table 26: In Vitro Diagnostics, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 27: In Vitro Diagnostics, Australia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 28: Clinical Chemistry, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 29: Genetic Testing, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 30: Haematology, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 31: Histology And Cytology, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 32: Immuno Chemistry, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 33: Infectious Immunology, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 34: Microbiology Culture, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 35: In Vitro Diagnostics, Australia, Company Share, USD Constant, (2010-2011)
Table 36: Clinical Chemistry, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 37: Genetic Testing, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 38: Haematology, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 39: Histology And Cytology, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 40: Immuno Chemistry, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 41: Infectious Immunology, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 42: Microbiology Culture, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 43: In Vitro Diagnostics, India, Overall Revenue ($m), USD Constant, 2004-2018
Table 44: In Vitro Diagnostics, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 45: In Vitro Diagnostics, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 46: Clinical Chemistry, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 47: Genetic Testing, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 48: Haematology, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 49: Histology And Cytology, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 50: Immuno Chemistry, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 51: Infectious Immunology, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 52: Microbiology Culture, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 53: In Vitro Diagnostics, India, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 54: Clinical Chemistry, India, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 55: Genetic Testing, India, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 56: Haematology, India, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 57: Histology And Cytology, India, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 58: Immuno Chemistry, India, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 59: Infectious Immunology, India, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 60: Microbiology Culture, India, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 61: In Vitro Diagnostics, China, Overall Revenue ($m), USD Constant, 2004-2018
Table 62: In Vitro Diagnostics, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 63: In Vitro Diagnostics, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 64: Clinical Chemistry, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 65: Genetic Testing, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 66: Haematology, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 67: Histology And Cytology, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 68: Immuno Chemistry, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 69: Infectious Immunology, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 70: Microbiology Culture, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 71: In Vitro Diagnostics, China, Company Share, USD Constant, (2010-2011)
Table 72: Clinical Chemistry, China, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 73: Genetic Testing, China, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 74: Haematology, China, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 75: Histology And Cytology, China, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 76: Immuno Chemistry, China, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 77: Infectious Immunology, China, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 78: Microbiology Culture, China, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 79: Clinical Chemisty Market Pipeline Products
Table 80: Immuno Chemistry Market Pipeline Products
Table 81: Haematology Market Pipeline Products
Table 82: Infectious Immunology Market Pipeline Products
Table 83: Microbiology Culture Market Pipeline Products
Table 84: Histology And Cytology Market Pipeline Products
Table 85: Genetic Testing Market Pipeline Products
Table 86: Nabi Biopharma Completes Merger With Biota
Table 87: Genting Invests $32 Million In TauRx Pharma
Table 88: PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech For $38 Million
Table 89: SK Telecom To Acquire 49% Stake In Xi'an Tianlong, In-vitro Diagnostics Company
Table 90: Fresenius Acquires 70% Stake In Huangshi Lishizhen Medicine Group Wuhan Xisu Pharma From Huangshi Lishizhen Medicine Group Wuhan Lishizhen Medicine
Table 91: Wuhan Humanwell Hi-tech Industry To Acquire 80% Stake In Beijing Baron Medical Equipment For $123 Million
Table 92: OriGene Technologies Acquires Beijing Zhongshan Golden Bridge Biotechnology, Pathology Testing Products Provider
Table 93: Shanghai Fosun Pharma Acquires 17.65% Stake In SD Biosensor, In Vitro Diagnostics Company
Table 94: Mindray Medical Completes Acquisition Of Controlling Stake In Hunan Changsha Tiandiren Biotech For $3 Million
Table 95: Swift Biosciences Enters Into Licensing Agreement With Vela Diagnostics For Cancer Detection Technology
Table 96: Cisbio Bioassays Enters Into Distribution Agreement With BellBrook Labs For Transcreener Epigen Methyltransferase Assay
Table 97: Institute of Microelectronics Enters Into Co-Development Agreement With SFC Fluidics
Table 98: Pressure BioSciences Enters Into Co-Marketing Agreement With Constant Systems For High Pressure Technologies
Table 99: Takara Bio Enters Into Co-Marketing Agreement With Pathogenica For HAI Sequencing Service
Table 100: bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology
Table 101: Clinical Genomics Enters Into Licensing Agreement With Quest Diagnostics For Colon Cancer Markers
Table 102: Abaxis Enters Into Distribution Agreement With Abbott Point of Care For Piccolo Blood Chemistry System
Table 103: Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System
Table 104: Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ
Table 105: BG Medicine Enters Into Agreement With Wuhan Kindstar Diagnostics For Galectin-3 Testing
Table 106: BioDot Enters Into Co-Marketing Agreement With JOT Automation
Table 107: BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays
Table 108: Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery
Table 109: Vela Diagnostics Enters Into Licensing Agreement With Life Technologies
Table 110: CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions
Table 111: Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test
Table 112: Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology
Table 113: CML HealthCare Enters Into Agreement With MaRS Innovation
Table 114: Akrivis Technologies Enters Into Co-Development Agreement With United States Biological
Table 115: Qiagen Enters Into Co-Marketing Agreement With Lepu Medical
Table 116: Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test
Table 117: Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products
Table 118: GVK Biosciences Enters Into Licensing Agreement With National Cancer Institute For GOBIOM Database
Table 119: GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina
Table 120: Affymetrix Enters Into Co-Development Agreement With Pathgen Dx
Table 121: Dolomite Centre Enters Into Licensing Agreement With Japan Science and Technology Agency For Microdroplet Generation Technology
Table 122: Edan Instruments And Edan Diagnostics Form Joint Venture With Xizeng Shi
Table 123: NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests
Table 124: Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test
Table 125: DiaSorin Forms Joint Venture With Trivitron Healthcare
Table 126: Ahn-Gook Pharma Enters Into Licensing Agreement With Ceragem Medisys
Table 127: Siemens Healthcare Diagnostics Enters Into Distribution Agreement With Sysmex
Table 128: Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers
Table 129: SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
Table 130: Sysmex Asia Pacific Enters Into Distribution Agreement With DiaSys Diagnostic Systems
Table 131: Immuno-Biological Labs Enters Into Licensing Agreement With IBL International
Table 132: Molecular Discovery Enters Into Co Development Agreement With Peter MacCallum Cancer Centre
Table 133: MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
Table 134: Guided Therapeutics Extends Licensing And Co-Development Agreement With Konica Minolta
Table 135: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
Table 136: Immuno-Biological Labs To Form Joint Venture With TransGenic
Table 137: Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis
Table 138: Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test
Table 139: One Lambda Enters Into Co-Marketing Agreement With CellTrend
Table 140: Fujitsu Taiwan Enters Into Co-Development Agreement With National Cheng Kung University
Table 141: GE Healthcare Enters Into Co-Development Agreement With Commonwealth Scientific and Industrial Research
Table 142: Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test
Table 143: Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker
Table 144: Insight Genetics Enters Into Licensing Agreement With Kindstar Globalgene Technology For ALK Screen Biomaker
Table 145: Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
Table 146: AITbiotech Enters Into Licensing Agreement With Exploit Technologies For H5N1 Test Kit
Table 147: Seegene Enters Into Co-Development Agreement With DuPont Nutrition & Health To Develop Multiplexed Assays For Food Safety Testing
Table 148: Prosolia Enters Into Licensing Agreement With AB Sciex For ORNL Analytical Technology
Table 149: Everist Genomics Enters Into Joint Venture Agreement With Manipal Group
Table 150: Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
Table 151: Pacific Biosciences Enters Into Co-Marketing Agreement With Tomy Digital Biology
Table 152: Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology
Table 153: Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA
Table 154: HealthLinx Enters Into Distribution Agreement With INEX Innovations Exchange And Metropolis Healthcare For OvPlex
Table 155: Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit
Table 156: Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo
Table 157: Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For Pressure Cycling Technology
Table 158: Ezose Sciences Enters Into Co-Development Agreement With Hirosaki University For New Cancer Biomarkers
Table 159: LipoScience Enters Into Licensing Agreement With Cleveland Clinic
Table 160: GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System
Table 161: Metabolon Enters Into Co-Development Agreement With Takeda Pharma
Table 162: GE Healthcare Enters Into Research Agreement With Clino
Table 163: Sysmex Extends Distribution Agreement With Roche
Table 164: NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers
Table 165: Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX
Table 166: Molecular Response Enters Into Co-Marketing Agreement With Transparent
Table 167: A-STAR Enters Into Co-Development Agreement With QuantuMDx Group
Table 168: Epistem Holdings Enters Into Co-Marketing Agreement With Xcelris Labs For Molecular Tuberculosis Diagnostic Test
Table 169: VolitionRx And Abcodia Partner To Advance Discovery Of Blood Based Biomarkers For Cancer
Table 170: Thermo Fisher Scientific Extends Licensing Agreement With Wako Pure Chemical Industries
Table 171: SQI Diagnostics Enters Into Distribution Agreement With Integrated Sciences
Table 172: Avesthagen Enters Into Co-Development Agreement With CosmosID
Table 173: GeneNews Forms Joint Venture With Shanghai Biochip For Sentinel Centre For Personalized Medicine
Table 174: Life Technologies Enters Into Joint Venture Agreement With DaAn Gene
Table 175: ZyGEM Enters Into Co-Development Agreement With USAMRIID
Table 176: BioTime Enters Into Distribution Agreement With USCN Life Science

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018
Figure 2: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018
Figure 3: In Vitro Diagnostics, Asia-Pacific, Cross-Category Analysis, 2004-2018
Figure 4: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 5: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 6: In Vitro Diagnostics, Asia-Pacific, Company share (%), 2011
Figure 7: In Vitro Diagnostics, Japan, Overall Revenue ($m), USD Constant, 2004-2018
Figure 8: In Vitro Diagnostics, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 9: In Vitro Diagnostics, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 10: In Vitro Diagnostics, Japan, Company Share (%), 2011
Figure 11: Clinical Chemistry, Japan, Company Share (%), 2011
Figure 12: Genetic Testing, Japan, Company Share (%), 2011
Figure 13: Haematology, Japan, Company Share (%), 2011
Figure 14: Histology And Cytology, Japan, Company Share (%), 2011
Figure 15: Immuno Chemistry, Japan, Company Share (%), 2011
Figure 16: Infectious Immunology, Japan, Company Share (%), 2011
Figure 17: Microbiology Culture, Japan, Company Share (%), 2011
Figure 18: In Vitro Diagnostics, Australia, Overall Revenue ($m), USD Constant, 2004-2018
Figure 19: In Vitro Diagnostics, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 20: In Vitro Diagnostics, Australia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 21: In Vitro Diagnostics, Australia, Company Share (%), 2011
Figure 22: Clinical Chemistry, Australia, Company Share (%), 2011
Figure 23: Genetic Testing, Australia, Company Share (%), 2011
Figure 24: Haematology, Australia, Company Share (%), 2011
Figure 25: Histology And Cytology, Australia, Company Share (%), 2011
Figure 26: Immuno Chemistry, Australia, Company Share (%), 2011
Figure 27: Infectious Immunology, Australia, Company Share (%), 2011
Figure 28: Microbiology Culture, Australia, Company Share (%), 2011
Figure 29: In Vitro Diagnostics, India, Overall Revenue ($m), USD Constant, 2004-2018
Figure 30: In Vitro Diagnostics, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 31: In Vitro Diagnostics, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 32: In Vitro Diagnostics, India, Company Share (%), 2011
Figure 33: Clinical Chemistry, India, Company Share (%), 2011
Figure 34: Genetic Testing, India, Company Share (%), 2011
Figure 35: Haematology, India, Company Share (%), 2011
Figure 36: Histology And Cytology, India, Company Share (%), 2011
Figure 37: Immuno Chemistry, India, Company Share (%), 2011
Figure 38: Infectious Immunology, India, Company Share (%), 2011
Figure 39: Microbiology Culture, India, Company Share (%), 2011
Figure 40: In Vitro Diagnostics, China, Overall Revenue ($m), USD Constant, 2004-2018
Figure 41: In Vitro Diagnostics, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 42: In Vitro Diagnostics, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 43: In Vitro Diagnostics, China, Company Share (%), 2011
Figure 44: Clinical Chemistry, China, Company Share (%), 2011
Figure 45: Genetic Testing, China, Company Share (%), 2011
Figure 46: Haematology, China, Company Share (%), 2011
Figure 47: Histology And Cytology, China, Company Share (%), 2011
Figure 48: Immuno Chemistry, China, Company Share (%), 2011
Figure 49: Infectious Immunology, China, Company Share (%), 2011
Figure 50: Microbiology Culture, China, Company Share (%), 2011
Figure 51: F. Hoffmann-La Roche Ltd., Company Share (%), Asia-Pacific In Vitro Diagnostics Market, 2011
Figure 52: Siemens Healthcare, Company Share (%), Asia-Pacific In Vitro Diagnostics Market, 2011
Figure 53: Abbott Laboratories, Company Share (%), Asia-Pacific In Vitro Diagnostics Market, 2011
Figure 54: Sysmex Corporation, Company Share (%), Asia-Pacific In Vitro Diagnostics Market, 2011
Figure 55: Beckman Coulter, Inc., Company Share (%), Asia-Pacific In Vitro Diagnostics Market, 2011
Figure 56: Ortho-Clinical Diagnostics Inc., Company Share (%), Asia-Pacific In Vitro Diagnostics Market, 2011

F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
Sysmex Corporation
Beckman Coulter, Inc.
Ortho-Clinical Diagnostics Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
bioMerieux S.A.
Eiken Chemical Co.,Ltd.
Shanghai Kehua Bio-engineering Co., Ltd
Mindray Medical International Limited
Alere Inc.
Transasia Bio-Medicals Ltd.
Nihon Kohden Corporation
Horiba, Ltd.
Qiagen N.V.
DiaSorin S.p.A
PerkinElmer, Inc.
Tosoh Corporation
Danaher Corporation
Thermo Fisher Scientific Inc.
Gen-Probe Incorporated
Span Diagnostics Ltd.
Diagnostica Stago, Inc.
Agappe Diagnostics Ltd.
Life Technologies Corporation
Grifols, S.A.
Trivitron Healthcare Pvt Ltd.
Himedia Laboratories Pvt. Ltd.
Tulip Diagnostics (P) Ltd

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos